Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 600.27 K1.71 M2.29 M1.48 M 6.08 M Research & development ———— — Operating income -15.18 M-12.39 M-5.31 M-15.45 M -48.33 M Non-Operating Income, Total 30.78 M30.63 M31.65 M31.24 M 124.29 M Interest expense, net of interest capitalized 6.3 M900 K1.11 M1.19 M 9.5 M Non-Operating Income, excl. Interest Expenses 24.48 M29.73 M30.53 M29.93 M 114.67 M Unusual income/expense 0——120 K — Pretax income 1.94 M5.87 M14.43 M3.22 M 25.46 M Equity in earnings ———— — Taxes -16.56 K-11.31 K-204.68 K23.37 K -209.18 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -6.9 M13.29 M12 M-2.61 M 15.77 M Discontinued operations ———— — Net income -6.9 M13.29 M12 M-2.61 M 15.77 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -6.9 M13.29 M12 M-2.61 M 15.77 M Basic earnings per share (Basic EPS) -0.420.840.74-0.18 0.98 Diluted earnings per share (Diluted EPS) -0.420.840.74-0.18 0.98 Average basic shares outstanding 16.25 M15.78 M16.11 M15.85 M — Diluted shares outstanding 16.25 M15.78 M16.11 M15.85 M — EBITDA -15.5 M-11.45 M-5.46 M-14.93 M -47.33 M EBIT -15.18 M-12.39 M-5.31 M-15.45 M -48.33 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) -313.69 K942.14 K-151.97 K518.29 K 994.77 K